Roche Acquires Promedior for Up to US$1.4 B

By Michelle Liu

Pharma Deals Review: Vol 2019 Issue 11 (Table of Contents)

Published: 21 Nov-2019

DOI: 10.3833/pdr.v2019.i11.2470     ISSN: 1756-7874

Section: Mergers & Acquisitions



A year after Bristol-Myers Squibb declined an option to acquire it in 2018, Promedior has found another buyer in Roche which has agreed to pay up to US$1...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details